dalteparin has been researched along with Migraine Disorders in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estey, A | 1 |
| Lynch, T | 1 |
| Lim, RK | 1 |
1 other study available for dalteparin and Migraine Disorders
| Article | Year |
|---|---|
Cerebral sinovenous thrombosis masquerading as migraine: a case report.
Topics: Anticoagulants; Child; Diagnosis, Differential; Enoxaparin; Humans; Injections, Subcutaneous; Magnet | 2009 |